​
​

Deciphera Pharmaceuticals (DCPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Deciphera Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$163.36M

Latest Revenue (Q)

$45.00M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Deciphera Pharmaceuticals Revenue by Period

Deciphera Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$163.36M21.87%
2022-12-31$134.04M39.41%
2021-12-31$96.15M128.45%
2020-12-31$42.09M68.35%
2019-12-31$25.00M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Deciphera Pharmaceuticals generated $163.36M in revenue during NA 2023, up 21.87% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Deciphera Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-03-31$45.00M-6.82%
2023-12-31$48.29M11.50%
2023-09-30$43.31M13.08%
2023-06-30$38.30M14.53%
2023-03-31$33.45M-7.98%
2022-12-31$36.34M1.03%
2022-09-30$35.97M10.71%
2022-06-30$32.49M11.19%
2022-03-31$29.22M20.76%
2021-12-31$24.20M4.22%
2021-09-30$23.22M-1.50%
2021-06-30$23.57M-6.29%
2021-03-31$25.16M29.10%
2020-12-31$19.49M26.13%
2020-09-30$15.45M117.90%
2020-06-30$7.09M11335.48%
2020-03-31$62.00K100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$25.00M100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Deciphera Pharmaceuticals generated $45.00M in revenue during Q1 2024, up -6.82% compared to the previous quarter, and up 123.81% compared to the same period a year ago.

Deciphera Pharmaceuticals Revenue Breakdown

Deciphera Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Product$159.07M----
Collaboration Arrangement$4.28M$8.53M$8.76M$2.63M-
License----$25.00M

Deciphera Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (97.38%), and Collaboration Arrangement (2.62%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Jun 19
Collaboration Arrangement$12.00M-$12.00M$984.00K$223.00K$3.46M$3.66M$997.00K$414.00K$502.00K$1.54M$1.52M$5.19M$14.00K$200.00K$100.00K--
Product$42.55M$117.25M$41.82M$4.83M--------------
License----------------$100.00K$25.00M

Deciphera Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (78.00%), and Collaboration Arrangement (22.00%).

Deciphera Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
GERMANY$17.96M$14.30M--
UNITED STATES$121.55M$97.22M$81.48M$38.00M
Non-US$19.57M$28.29M$5.91M$1.50M

Deciphera Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (76.41%), Non-US (12.30%), and GERMANY (11.29%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
UNITED STATES$31.84M$35.34M$32.66M$28.92M$24.62M$25.59M$24.48M$23.73M$23.41M$21.48M$19.98M$20.73M$19.29M$18.50M$14.70M
Non-US$10.71M-$9.16M$8.40M$8.60M$7.29M$7.84M$7.76M$5.40M$2.21M$1.71M$1.32M$675.00K$1.00M$500.00K

Deciphera Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (74.82%), and Non-US (25.18%).

Deciphera Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
NBIXNeurocrine Biosciences$1.89B$622.10M
ALKSAlkermes$1.66B$378.14M
PBHPrestige Consumer Healthcare$1.13B$283.55M
PAHCPhibro Animal Health$977.89M$273.16M
EVOEvotec SE$781.43M$208.73M
SUPNSupernus Pharmaceuticals$607.52M$175.69M
AMPHAmphastar Pharmaceuticals$593.24M$188.82M
COLLCollegium Pharmaceutical$566.77M$159.30M
ANIPANI Pharmaceuticals$486.82M$148.33M
IRWDIronwood Pharmaceuticals$442.74M$91.59M
PROCProcaps Group$409.92M$118.41M
EGRXEagle Pharmaceuticals$316.61M$64.65M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M
AVDLAvadel Pharmaceuticals$27.96M$50.02M
SSICSilver Spike Investment$11.72M$2.76B

DCPH Revenue FAQ

What is Deciphera Pharmaceuticals’s yearly revenue?

Deciphera Pharmaceuticals's yearly revenue for 2023 was $163.36M, representing an increase of 21.87% compared to 2022. The company's yearly revenue for 2022 was $134.04M, representing an increase of 39.41% compared to 2021. DCPH's yearly revenue for 2021 was $96.15M, representing an increase of 128.45% compared to 2020.

What is Deciphera Pharmaceuticals’s quarterly revenue?

Deciphera Pharmaceuticals's quarterly revenue for Q1 2024 was $45M, a -6.82% decrease from the previous quarter (Q4 2023), and a 34.55% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $48.29M, a 11.50% increase from the previous quarter (Q3 2023), and a 32.88% increase year-over-year (Q4 2022). DCPH's quarterly revenue for Q3 2023 was $43.31M, a 13.08% increase from the previous quarter (Q2 2023), and a 20.40% increase year-over-year (Q3 2022).

What is Deciphera Pharmaceuticals’s revenue growth rate?

Deciphera Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 69.90%, and for the last 5 years (2019-2023) was 553.42%.

What are Deciphera Pharmaceuticals’s revenue streams?

Deciphera Pharmaceuticals's revenue streams in c 23 are Product, and Collaboration Arrangement. Product generated $159.07M in revenue, accounting 97.38% of the company's total revenue Collaboration Arrangement generated $4.28M in revenue, accounting 2.62% of the company's total revenue, down -49.81% year-over-year.

What is Deciphera Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Deciphera Pharmaceuticals was Product. This segment made a revenue of $159.07M, representing 97.38% of the company's total revenue.